2 unknown. 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Laboratorios Roemmers S.A.I.C.F.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts Nitazoxanide, Placebo - Covid19, SARS-CoV-2 Infection | Phase 4 | Unknown | Fundación Huésped | 456 | 2020-12-01 | 2021-07-02 |
| Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19) Nitazoxanide, Placebo - COVID-19 | Phase 2 / Phase 3 | Unknown | Laboratorios Roemmers S.A.I.C.F. | 135 | 2020-06-26 | 2020-10-08 |
COVID-19 (2) · Coronavirus Infections (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
nitazoxanide (2)
Argentina (2)
Herman K Ludvik, MD (1) · Marcelo Silva, MD (1) · Omar Sued, MD PhMD (1)